85 related articles for article (PubMed ID: 737791)
1. [Treatment of Wilson's disease using triethylenetetramine dihydrochloride (TETA)].
Hauftová D; Körbel J; Jancík F; Kuhr I; Ferenc M
Cesk Gastroenterol Vyz; 1978 Dec; 32(8):538-9. PubMed ID: 737791
[No Abstract] [Full Text] [Related]
2. [Triethylene tetramine in Wilson's disease].
Rave D; Vengrover D; Kleinman J; Leitersdorf E
Harefuah; 1986 Feb; 110(4):178-9. PubMed ID: 3721331
[No Abstract] [Full Text] [Related]
3. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
Haslam RH; Sass-Kortsak A; Stout W; Berg M
Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
[TBL] [Abstract][Full Text] [Related]
4. Drug therapy in Wilson's disease.
Reed K
J Am Optom Assoc; 1988 Jun; 59(6):438. PubMed ID: 3403885
[No Abstract] [Full Text] [Related]
5. Trientine for Wilson's disease.
Med Lett Drugs Ther; 1986 Jul; 28(717):67. PubMed ID: 3724656
[No Abstract] [Full Text] [Related]
6. The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1).
Walshe JM
Prog Clin Biol Res; 1979; 34():271-80. PubMed ID: 531055
[No Abstract] [Full Text] [Related]
7. Treatment of Wilson's disease.
Brewer GJ; Yuzbasiyan-Gurkan V; Young AB
Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455
[No Abstract] [Full Text] [Related]
8. [Trientin in Wilson's disease. Therapeutic possibilities in patients who cannot tolerate penicillamine].
Ritland S
Tidsskr Nor Laegeforen; 1987 Aug; 107(22):1770-1. PubMed ID: 3660361
[No Abstract] [Full Text] [Related]
9. Neurological abnormalities in Wilson's disease are reversible.
Lingam S; Wilson J; Nazer H; Mowat AP
Neuropediatrics; 1987 Feb; 18(1):11-2. PubMed ID: 3561699
[TBL] [Abstract][Full Text] [Related]
10. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
Günther K; Siegemund R; Lössner J; Kühn HJ
Radiobiol Radiother (Berl); 1988; 29(2):226-9. PubMed ID: 3399664
[No Abstract] [Full Text] [Related]
11. The management of pregnancy in Wilson's disease treated with trientine.
Walshe JM
Q J Med; 1986 Jan; 58(225):81-7. PubMed ID: 3704107
[TBL] [Abstract][Full Text] [Related]
12. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease.
Scheinberg IH; Jaffe ME; Sternlieb I
N Engl J Med; 1987 Jul; 317(4):209-13. PubMed ID: 3600712
[TBL] [Abstract][Full Text] [Related]
13. Preparation of and clinical experiences with trien for the treatment of Wilson's disease in absolute intolerance of D-penicillamine.
Harders H; Cohnen E
Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):10-2. PubMed ID: 122652
[No Abstract] [Full Text] [Related]
14. The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease.
Yarze JC
Am J Gastroenterol; 1995 Jun; 90(6):1026. PubMed ID: 7771405
[No Abstract] [Full Text] [Related]
15. Wilson's disease and pregnancy.
Sternlieb I
Hepatology; 2000 Feb; 31(2):531-2. PubMed ID: 10655282
[No Abstract] [Full Text] [Related]
16. Two male patients with Wilson's disease treated using trientine and iron reduction therapy.
Hayashi H; Ueno T; Yano M; Okada T; Mabuchi H
J Gastroenterol Hepatol; 2005 Oct; 20(10):1627-8. PubMed ID: 16174091
[No Abstract] [Full Text] [Related]
17. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine).
Dahlman T; Hartvig P; Löfholm M; Nordlinder H; Lööf L; Westermark K
QJM; 1995 Sep; 88(9):609-16. PubMed ID: 7583074
[TBL] [Abstract][Full Text] [Related]
19. Neurological Wilson's disease.
McIntyre N
Q J Med; 1993 May; 86(5):349-50. PubMed ID: 8327653
[No Abstract] [Full Text] [Related]
20. Cold comfort pharm.
Will RG
Pract Neurol; 2008 Feb; 8(1):60-1. PubMed ID: 18230710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
